Once considered highly technical, droplet digital PCR is undergoing a minor revolution as a quality-control tool. A look at new applications. #AdFeature with Bio-Rad Life Science

Two complementary workflows have been developed that can be performed alongside traditional PCR testing methods #AdFeature with Illumina

A new six-colour digital PCR system that rapidly detects tumour mutations could help guide faster treatment of diseases such as non-small cell lung cancer #AdFeature with Stilla Technologies

The TRACERx study is revealing new insights into lung cancer evolution that could help predict which patients will respond to treatments #AdFeature with Cancer Research UK

A deeper understanding of the gut's microbiome through next-generation sequencing will help researchers better understand how our microbial inhabitants contribute to, or protect us from disease #AdFeature with Illumina

A new method of validating antibodies for post-translational modification studies should improve experimental reproducibility by greatly increasing specificity #AdFeature with Invitrogen

As SARS-CoV-2 testing raises demand for antibodies, how is supply keeping up – while maintaining quality? #AdFeature with Jackson ImmunoResearch

Pinpointing the role of microRNA in the circadian rhythm of skin cells could help identify methods to alleviate age-related damage #AdFeature with Estée Lauder

Next-generation sequencing is helping researchers to understand why individuals respond differently to SARS-CoV-2 infection #AdFeature with Illumina

Immuno-modulating therapies could calm dangerous cytokine storms, but only if clinicians can accurately monitor a patient’s immune response. #AdFeature with RayBiotech

Biobanking has been around for decades now, having grown from small niche projects to large national undertakings. But is bigger always better? How can we ensure representation for all of the population? #AdFeature with @Illumina

Can genomic technology help scientists prepare for the next pandemic? #AdFeature with Illumina

For scientists engineering high-affinity antibodies, a new programmable semiconductor platform makes the construction of higher-quality mutant libraries precise and fast. #Adfeature with GenScript

Tools such as CRISPR and machine learning are helping researchers screen for, and unlock the potential of synthetic lethality which could treat more patients with 'undruggable' cancers. #AdFeature with GSK

DNA variations drive many different cardiovascular diseases, but genetic testing is not yet widely used. Lack of awareness is part of the reason. #AdFeature with Illumina

Could AI take the pain out of antibody selection? A new machine-learning platform can scour scientific literature to identify high-affinity antibodies. #AdFeature with @Illumina

SARS-CoV-2 has driven the rapid development of a number of new vaccine technologies. The benefits will last long after the pandemic subsides. #AdFeature with GSK

Celebrating the power of scientific images: CAST’s Innovation Through the Lens annual global #PhotoContest seeks entries to document how science is changing the world. #AdFeature with China Association for Science and Technology

We're thrilled to announce the winners of the 2023 Nature Awards for Inspiring Women in Science: @HortenseLeFerra in the Achievement category, and the Main Bhi Curie programme from SwaTaleem Foundation in the Outreach category! Learn more: go.nature.com/3j5IT2m #WomeninSTEM

#Ad Join SAMPS Boston 2023 to learn about the latest AI trends in Scientific Sales and Marketing! Exclusive 15% off with code “Nature”. #sampslive events.samps.org/#registration